D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 88 Citations 51,260 484 World Ranking 8181 National Ranking 285

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Cardiology
  • Atrial fibrillation

The scientist’s investigation covers issues in Atrial fibrillation, Internal medicine, Cardiology, Heart failure and Catheter ablation. The concepts of his Atrial fibrillation study are interwoven with issues in Stroke, Randomized controlled trial, Heart disease and Intensive care medicine. His research integrates issues of Endocrinology and Surgery in his study of Internal medicine.

In the subject of general Cardiology, his work in Electrocardiography is often linked to In patient, thereby combining diverse domains of study. He has included themes like Oxidative stress, Cardiotoxicity, Chemotherapy, Bioinformatics and Heart rate in his Heart failure study. Harry J.G.M. Crijns combines subjects such as Platelet aggregation inhibitor, Vitamin K antagonist, Cardiac arrhythmia and Atrial flutter with his study of Catheter ablation.

His most cited work include:

  • Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. (4091 citations)
  • A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey. (2807 citations)
  • 2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: Recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design (2370 citations)

What are the main themes of his work throughout his whole career to date?

His scientific interests lie mostly in Internal medicine, Cardiology, Atrial fibrillation, Heart failure and Sinus rhythm. His Internal medicine study frequently intersects with other fields, such as Anesthesia. As part of his studies on Cardiology, Harry J.G.M. Crijns frequently links adjacent subjects like Surgery.

His Atrial fibrillation study combines topics from a wide range of disciplines, such as Stroke, Ablation and Intensive care medicine. His Heart failure study incorporates themes from Randomized controlled trial, Quality of life and Hazard ratio. His Cardiac resynchronization therapy research is multidisciplinary, incorporating perspectives in QRS complex and Left bundle branch block.

He most often published in these fields:

  • Internal medicine (79.61%)
  • Cardiology (68.98%)
  • Atrial fibrillation (63.34%)

What were the highlights of his more recent work (between 2019-2021)?

  • Internal medicine (79.61%)
  • Atrial fibrillation (63.34%)
  • Cardiology (68.98%)

In recent papers he was focusing on the following fields of study:

Harry J.G.M. Crijns mainly focuses on Internal medicine, Atrial fibrillation, Cardiology, Heart failure and In patient. His studies examine the connections between Internal medicine and genetics, as well as such issues in Diabetes mellitus, with regards to Heart rate variability. His Atrial fibrillation research includes elements of Stroke, mHealth and Emergency department.

His Stroke research is multidisciplinary, incorporating elements of Off-label use, Intensive care medicine, Dosing, Edoxaban and Cohort. Harry J.G.M. Crijns works mostly in the field of Cardiology, limiting it down to topics relating to Odds ratio and, in certain cases, Logistic regression, as a part of the same area of interest. His Heart failure research incorporates themes from Cardiac sarcoidosis, Risk stratification, High morbidity, Risk factor and Comorbidity.

Between 2019 and 2021, his most popular works were:

  • Early Rhythm-Control Therapy in Patients with Atrial Fibrillation (110 citations)
  • Thrombo-Inflammation in Cardiovascular Disease: An Expert Consensus Document from the Third Maastricht Consensus Conference on Thrombosis. (21 citations)
  • Atrial fibrillation progression risk factors and associated cardiovascular outcome in well-phenotyped patients: data from the AF-RISK study (14 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Cardiology
  • Myocardial infarction

His primary areas of investigation include Atrial fibrillation, Internal medicine, Cardiology, Heart failure and Stroke. His Atrial fibrillation research includes themes of mHealth and Randomized controlled trial. His work carried out in the field of Randomized controlled trial brings together such families of science as Apixaban and Clinical trial.

His work in the fields of Internal medicine, such as Heart rate variability, overlaps with other areas such as Research design. The Cardiology study combines topics in areas such as Odds ratio and Prediabetes. The various areas that Harry J.G.M. Crijns examines in his Stroke study include Coronary artery disease, Intensive care medicine, Thrombosis, Risk factor and Comorbidity.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation.

Gregory Y. H. Lip;Robby Nieuwlaat;Ron Pisters;Deirdre A. Lane.
Chest (2010)

8317 Citations

A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey.

Ron Pisters;Deirdre A. Lane;Robby Nieuwlaat;Cees B. de Vos.
Chest (2010)

4591 Citations

2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: Recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design

Hugh Calkins;Karl Heinz Kuck;Riccardo Cappato;Josep Brugada.
Europace (2012)

4493 Citations

2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design

Hugh Calkins;Karl Heinz Kuck;Riccardo Cappato;Josep Brugada.
Journal of Interventional Cardiac Electrophysiology (2012)

4139 Citations

HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: Recommendations for personnel, policy, procedures and follow-up. A report of the Heart Rhythm Society (HRS) Task Force on catheter and surgical ablation of atrial fibrillation

Hugh Calkins;Josep Brugada;Douglas L. Packer;Ricardo Cappato.
Europace (2008)

1848 Citations

Doxorubicin-induced cardiomyopathy: From molecular mechanisms to therapeutic strategies

Yanti Octavia;Carlo G. Tocchetti;Kathleen L. Gabrielson;Stefan Janssens.
Journal of Molecular and Cellular Cardiology (2012)

1345 Citations

Atrial fibrillation management: a prospective survey in ESC Member Countries The Euro Heart Survey on Atrial Fibrillation

Robby Nieuwlaat;Alessandro Capucci;A John Camm;S Bertil Olsson.
European Heart Journal (2005)

1221 Citations

2011 ACCF/AHA/HRS Focused Updates Incorporated Into the ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines

Valentin Fuster;Lars E. Rydén;Davis S. Cannom;Harry J. Crijns.
Circulation (2011)

1138 Citations

Increased Mortality after Dronedarone Therapy for Severe Heart Failure

Lars Køber;Christian Torp-Pedersen;John J.V. McMurray;Ole Gøtzsche.
The New England Journal of Medicine (2008)

1119 Citations

Galectin-3 marks activated macrophages in failure-prone hypertrophied hearts and contributes to cardiac dysfunction.

Umesh C. Sharma;Saraswati Pokharel;Thomas J. van Brakel;Jop H. van Berlo.
Circulation (2004)

1023 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Harry J.G.M. Crijns

Gregory Y.H. Lip

Gregory Y.H. Lip

University of Liverpool

Publications: 1102

Paulus Kirchhof

Paulus Kirchhof

University of Birmingham

Publications: 231

Jonathan P. Piccini

Jonathan P. Piccini

Duke University

Publications: 168

Deirdre A. Lane

Deirdre A. Lane

University of Liverpool

Publications: 161

Shih-Ann Chen

Shih-Ann Chen

Taipei Veterans General Hospital

Publications: 160

Andrea Natale

Andrea Natale

Case Western Reserve University

Publications: 148

Prashanthan Sanders

Prashanthan Sanders

University of Adelaide

Publications: 148

Luigi Di Biase

Luigi Di Biase

Albert Einstein College of Medicine

Publications: 135

Gerhard Hindricks

Gerhard Hindricks

Leipzig University

Publications: 125

Jonathan M. Kalman

Jonathan M. Kalman

University of Melbourne

Publications: 116

A. John Camm

A. John Camm

St George's, University of London

Publications: 116

Hugh Calkins

Hugh Calkins

Johns Hopkins University

Publications: 113

Karl-Heinz Kuck

Karl-Heinz Kuck

Universität Hamburg

Publications: 111

Stanley Nattel

Stanley Nattel

Montreal Heart Institute

Publications: 105

Isabelle C. Van Gelder

Isabelle C. Van Gelder

University Medical Center Groningen

Publications: 105

Giuseppe Boriani

Giuseppe Boriani

University of Modena and Reggio Emilia

Publications: 102

Trending Scientists

Chris North

Chris North

Virginia Tech

Jeffrey J. Derby

Jeffrey J. Derby

University of Minnesota

Juan M. Coronado

Juan M. Coronado

Spanish National Research Council

Pilar Viñas

Pilar Viñas

University of Murcia

Lukas A. Mueller

Lukas A. Mueller

Boyce Thompson Institute

Eva Stoger

Eva Stoger

University of Natural Resources and Life Sciences

Hava Avraham

Hava Avraham

Northeastern University

Li-Hua Xu

Li-Hua Xu

Yunnan University

Carl J. Douglas

Carl J. Douglas

University of British Columbia

Jean-Jacques Peucat

Jean-Jacques Peucat

University of Rennes

Yves Guéguen

Yves Guéguen

École Normale Supérieure

Jerome Brunelin

Jerome Brunelin

Association for Computational Linguistics

Asher Koriat

Asher Koriat

University of Haifa

Deborah J. Fidler

Deborah J. Fidler

Colorado State University

Stephan Baldus

Stephan Baldus

University of Cologne

Edith A. Perez

Edith A. Perez

Mayo Clinic

Something went wrong. Please try again later.